[{"indications": "Indications\u00a0HIV infection in combination with other antiretroviral drugs", "name": "ATAZANAVIR", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Protease inhibitors"], "cautions": "Cautions\u00a0\n(From Protease inhibitors: British National Formulary)\nCautions\u00a0Protease inhibitors are associated with hyperglycaemia and should be used with caution in diabetes (see Lipodystrophy Syndrome). Caution is also needed in patients with haemophilia who may be at increased risk of bleeding.; also concomitant use with drugs that prolong PR interval; cardiac conduction disorders; predisposition to QT interval prolongation (including electrolyte disturbances, concomitant\r\nuse of drugs that prolong QT interval); interactions: Appendix 1 (atazanavir)", "side-effects": "Side-effects\u00a0see notes above; also AV block (in children); less commonly mouth ulcers, dry mouth, hypertension, syncope,\r\nchest pain, dyspnoea, peripheral neuropathy, abnormal dreams, amnesia,\r\ndisorientation, depression, anxiety, weight changes, increased appetite,\r\ngynaecomastia, nephrolithiasis, urinary frequency, haematuria, proteinuria,\r\narthralgia, and alopecia; rarely hepatosplenomegaly,\r\noedema, palpitation, and abnormal gait; also reported, cholelithiasis,\r\ncholecystitis, and torsade de pointes", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/128409.htm", "doses": ["With low-dose ritonavir, 300\u00a0mg once daily; child 6\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0manufacturer advises use only if potential benefit\r\noutweighs risk; theoretical risk of hyperbilirubinaemia in neonate\r\nif used at term "}]